Intuitive Surgical, Inc. $ISRG Shares Purchased by Midwest Trust Co

Midwest Trust Co raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,710 shares of the medical equipment provider’s stock after purchasing an additional 3,656 shares during the quarter. Midwest Trust Co’s holdings in Intuitive Surgical were worth $14,629,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ISRG. Tobam lifted its position in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares during the period. Kilter Group LLC purchased a new position in Intuitive Surgical during the second quarter valued at approximately $27,000. Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical in the 2nd quarter worth approximately $30,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $27,000. Finally, Riggs Asset Managment Co. Inc. increased its holdings in Intuitive Surgical by 84.2% in the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 0.5%

NASDAQ:ISRG opened at $495.15 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08. The company has a fifty day simple moving average of $546.68 and a two-hundred day simple moving average of $510.62. The company has a market cap of $175.84 billion, a price-to-earnings ratio of 62.76, a price-to-earnings-growth ratio of 3.83 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period in the prior year, the firm earned $2.21 earnings per share. The business’s quarterly revenue was up 18.8% compared to the same quarter last year. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on ISRG shares. HSBC increased their target price on Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research report on Monday, January 26th. Barclays set a $712.00 price target on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. UBS Group reaffirmed a “neutral” rating on shares of Intuitive Surgical in a research note on Thursday, January 15th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Finally, Piper Sandler restated an “overweight” rating and issued a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $617.23.

Insider Activity

In related news, SVP Mark Brosius sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the sale, the senior vice president directly owned 907 shares in the company, valued at $496,455.52. This trade represents a 83.23% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the sale, the director owned 3,694 shares in the company, valued at $1,958,189.40. This trade represents a 86.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 55,530 shares of company stock worth $30,459,295. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.